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Abstract
The clinical spectrum of human disease caused by the roundworms Toxocara canis and
Toxocara cati ranges from visceral and ocular larva migrans to covert toxocariasis. The par-
asite is not typically recovered in affected tissues, so detection of parasite-specific antibod-
ies is usually necessary for establishing a diagnosis. The most reliable immunodiagnostic
methods use the Toxocara excretory-secretory antigens (TES-Ag) in ELISA formats to
detect Toxocara-specific antibodies. To eliminate the need for native parasite materials, we
identified and purified immunodiagnostic antigens using 2D gel electrophoresis followed by
electrospray ionization mass spectrometry. Three predominant immunoreactive proteins
were found in the TES; all three had been previously described in the literature: Tc-CTL-1,
Tc-TES-26, and Tc-MUC-3. We generated Escherichia coli expressed recombinant proteins
for evaluation in Luminex based immunoassays. We were unable to produce a functional
assay with the Tc-MUC-3 recombinant protein. Tc-CTL-1 and Tc-TES-26 were successfully
coupled and tested using defined serum batteries. The use of both proteins together gener-
ated better results than if the proteins were used individually. The sensitivity and specificity
of the assay for detecting visceral larval migrans using Tc-CTL-1 plus Tc-TES-26 was 99%
and 94%, respectively; the sensitivity for detecting ocular larval migrans was 64%. The com-
bined performance of the new assay was superior to the currently available EIA and could
potentially be employed to replace current assays that rely on native TES-Ag.
Author Summary
The roundworms Toxocara canis and Toxocara cati cause a broad spectrum of clinical dis-
ease in humans. Children are at particular risk of toxocariasis when they play in areas
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potentially contaminated with Toxocara eggs, such as playgrounds or sandboxes and
ingest embryonated roundworm eggs. Currently, diagnosis for toxocariasis relies on clini-
cal signs, history of exposure to puppies or kittens, laboratory findings (including eosino-
philia), and the detection of antibodies to Toxocara antigens. The enzyme immunoassay
using T. canis excretory secretory antigens from infective-stage larvae is the most useful
diagnostic test for toxocaral visceral larva migrans (VLM) and ocular larva migrans
(OLM) and is the preferred assay used by most laboratories in the U.S. and worldwide.
Although the EIA has been robust and reliable, improvement should be made in the speci-
ficity of the assay and the availability of a consistent antigen source. The crude TES-Ag
shows cross-reactivity with antibodies from other common helminth infections of humans
which reduces the usefulness of native, unfractionated TES Ag-based serodiagnosis in
regions where poly-parasitism is endemic. To improve the assay performance, target anti-
genic proteins from T. canis excretory secretory antigens were identified using 2D gel elec-
trophoresis. Three antigenic proteins sequences were found, expressed, and developed
into Luminex bead-based assays. The combined use of two recombinant antigens (Tc-
CTL-1 and Tc-TES-26) represents an improvement over the existing immunodiagnostic
methods that rely on native parasite materials. In the future, additional antigens could be
added from other parasites that cause larval migrans to form a single method for detecting
larval migrans syndromes.
Introduction
The roundworms Toxocara canis and Toxocara cati cause a broad spectrum of clinical disease
in humans ranging from visceral and ocular larva migrans to covert and common toxocariasis.
Children are at particular risk of toxocariasis when they play in areas, potentially contaminated
with Toxocara eggs, such as playgrounds or sandboxes and ingest embryonated roundworm
eggs. After ingestion, the eggs hatch in the gut and larvae disseminate hematogenously to the
lungs, liver, muscle, brain, and/or eyes. Once in the tissues, the larvae are unable to continue
their normal life cycle, and a local inflammatory response to larvae leads to the varied symp-
toms of toxocariasis (visceral, ocular larva migrans, and covert toxocariasis), and can lead to
cerebritis and eosinophilic meningitis when larvae enter the central nervous system [1–6]. A
third so-called “covert” form of toxocariasis has been linked to more subtle pulmonary and
cognitive dysfunctions [7–9],and even educational deficits [10].
Currently, diagnosis for toxocariasis relies on clinical signs, history of exposure to puppies
or kittens, laboratory findings (including eosinophilia), and the detection of antibodies to Tox-
ocara antigens. The enzyme immunoassay (EIA) using T. canis excretory secretory antigens
(TES-Ag) from infective-stage larvae is the most useful diagnostic test for toxocaral visceral
larva migrans (VLM) and ocular larva migrans (OLM) and is the preferred assay used by most
laboratories in the U.S. and worldwide [4, 11].The TES-Ag EIA has proven to be robust and
reliable, although questions about specificity and reduced sensitivity leave ample room for
improvement in laboratory diagnosis of toxocariasis [4, 6, 11]. In temperate countries, TES-Ag
EIA and TES-western blot can provide sufficient support for clinical suspicion; however, test-
ing is not widely available because of the limited availability of antigen made from T. canis lar-
vae. The proven TES-Ag cross-reactivity with antibodies from other common helminth
infections of humans also reduces the usefulness of native, unfractionated TES-Ag-based sero-
diagnosis in regions where poly-parasitism is endemic [6]. Recent efforts have focused on iden-
tification of recombinant proteins to improve sensitivity and specificity and to reduce reliance
Toxocariasis Bead Based Assay
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004168 October 20, 2015 2 / 14
on native parasite materials [4]. Several groups have cloned, expressed, and developed EIAs
based on recombinant antigens of the assay [12–16].Ultimately, a diagnostic method that uti-
lizes one or more recombinant diagnostic antigens could result in improved assays that are
more widely accessible to health care providers.
Our study aim was to identify one or more immunoreactive proteins found in the TES prod-
uct from T. canis infective larvae and to develop at least one of these recombinant proteins as a
diagnostic reagent in a multiplex bead format assay (Luminex) that could replace TES-Ag.
Materials and Methods
Ethics statement
All clinical samples used in this study were collected in previous studies with specific permis-
sion for future use of stored samples (CDC Study Protocol Number 3580). Samples were anon-
ymized and the study was performed in compliance with protocols approved by the ethical
review boards of the CDC.
Serum specimens
Four sets of defined sera were used: (1) Two hundred and four sera from cases with presumed
Toxocara spp. visceral larval migrans (VLM), based on the presence of clinical symptoms and
signs and reactivity in the in-house TES-Ag EIA [11] and TES-Ag Western blot;(2) Fifty sera
from cases of presumed Toxocara spp. ocular larval migrans (OLM) based on the presence of
clinical symptoms and signs only (positivity with TES-Ag Western blot is not required to
define OLM); (3) A control group consisting of two hundred and eighty eight sera from healthy
U.S. residents; (4) A convenience panel for cross-reactivity evaluation consisting of one hun-
dred and twenty U.S. patients infected with various infections other than Toxocara spp. and
fourteen sera from Egyptians negative to Toxocara spp. Each sample was not exhaustively
tested for all other parasites. Sets number 3 and number 4 were tested with TES-Ag Western
blot.
Five serum samples collected from people with no travel history outside the United States
were pooled and used as the ‘normal’ control serum pool. For TES 2D gel, we used a positive
anti-Baylisascaris procyonis serum from a baboon that developed severe neural larval migrans
after experimental infection with embryonated B. procyonis eggs. A Toxocara-positive serum
pool was prepared by combining in equal volume of 10 EIA—positive serum samples.
TES 2D gel electrophoresis and mass spectrometry (MS)
For 2D gel electrophoresis and mass spectrometry analysis we utilized TES-Ag provided by Dr.
Steven Kayes’ Laboratory at the University of South Alabama, Mobile, AL. Briefly, larvae from
artificially de-shelled embryonated T. canis eggs were cultured in RPMI 1640 at 37°C with satu-
rated humidity and gassed with 5% CO2. The culture supernatants containing TES-Ag were
collected, pooled, and concentrated [17]. Protein concentrations were determined using the
Bradford Protein Assay and BCA Protein Quantification Assay (Pierce Biotechnology Rock-
ford, IL). The 2D gel electrophoresis was performed following a protocol used previously [18].
Fifty μg of TES-Ag sample was separated on 11 cm, non-linear, pH 3–10 gradient Immobilized
pH Gradient (IPG) strips (Bio-Rad, Hercules, CA) and after isoelectric focusing, the second
dimension was carried out using Criterion XT 4–12% Bis-Tris pre-cast sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) gels. Three of the 2D gels were transferred to
nitrocellulose membranes and blotted and probed with a 1:50 dilution of a strong EIA positive
Toxocara human sera pool, negative human serum sample, or a B. procyonis positive serum;
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the fourth gel was stained using a mass-spectrometry compatible silver stain. Proteins were
chosen based on the comparative reactivity seen in the blots and were manually excised from
silver-stained 2D gels. The target proteins were digested with trypsin and the resulting peptides
analyzed by electrospray ionization mass spectrometry [18].The Mascot program was used to
identify proteins from peptide sequence databases from the mass spectrometry data.
Recombinant Antigen Preparation
Tc-CTL-1. The Tc-CTL-1 antigen is a 32 kDa C-type lectin secreted by T. canis larvae [19,
20]. The DNA encoding for Tc-CTL-1, minus the signal peptide at N-terminus was amplified
from T. canis larval cDNA library [21], subsequently subcloned in-frame into the E. coli expres-
sion vector pET41a (Novagen) with fusion Schistosoma japonicum Glutathione S-transferase
(GST) deleted and 6 His-tag expressed at C-terminus (NdeI/XhoI). The correct open reading
frame (ORF) was confirmed by double stranded sequencing using the vector flanking primers
(T7 promoter/T7 terminator). For expression of recombinant Tc-CTL-1 in bacteria, the
recombinant pET41a was transformed into BL21(DE3) Escherichia coli (Novagen) and
recombinant protein was expressed as insoluble inclusion bodies after being induced with
1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) at 30°C overnight. The induced cells
were collected by centrifugation at 5,000 g for 10 min at 4°C and lyzed with PBS, pH 7.4 con-
taining 1 mg/mL lysozyme, 30 μg/mL DNAse I and 1% Triton-X 100, then sonicated for 60 sec-
onds on 75% power for 3–5 times with 2 minutes interval. The inclusion bodies were washed
with PBS, pH 7.4 containing 0.5% Triton X-100 for three times and then were solubilized in
PBS, pH 7.4 + 8M urea and the recombinant protein was purified with immobilized metal
affinity chromatography (IMAC) as described [22]. The recombinant Tc-CTL-1 was stored in
1 x PBS, pH7.4 +6M urea.
Tc-TES-26. The cloning of Tc-TES-26 was reported previously [23].We optimized and
synthesized TES-26 gene based on UniProtKB/Swiss-Prot: P54190.1sequence for bacterial
expression system [23] through a commercial company (Genscript). The plasmid, pGS21a-
TES26, was transformed into BL21(DE3) E. coli under selection of 35 μg/mL chloramphenicol
and 100 μg/mL ampicillin. The cultures were incubated in 30°C at 225 rpm. Once cell density
reached to optical density (OD) = 0.6 at 600 nm, 1 mM IPTG was introduced for induction at
37°C for 3 hours. After IPTG induction, the bacterial culture was harvested by centrifugation at
5,000 rpm, 4°C for 20 minutes. The pellet was resuspended in PBS + 1% Triton X-100 + lyso-
zyme 1 mg/mL. The mixture was incubated on ice for one hour, and then sonicated for 2 min-
utes at 65% power using a Misonix S-4000 ultrasonic liquid processor. After centrifugation, the
supernatant contained the soluble target protein. The recombinant GST fusion protein was
purified using glutathione Sepharose 4B affinity column (GE Healthcare) and the GST tag
from the fusion protein was not deleted for future coupling uses. Protein concentration was
determined using Bradford Protein Assay.
Tc-MUC-3. Tc-MUC-3 belongs to the TES-120 family of glycoproteins secreted by T.
canis. The protein contains a repetitive serine/threonine-rich tract, and 4 of 36-amino acid six-
cysteine (SXC) domains [24],and the sequence (AAD49340.1) was reported by Tetteh et al.
[21].The gene was cloned into the pGs21a expression vector and the protein was expressed by
a commercial company (Genscript, Piscataway, NJ). The plasmid was transformed into BL21
(DE3) E. coli and grew under selection of 100 μg/mL ampicillin at 37°C with shaking at 200
rpm. Once the cell density reached to OD = 1.3 at 600 nm, the induction was done with 1 mM
IPTG at 15°C overnight with shaking at 200 rpm. Cells were collected by centrifugation at
8,000 g, 4°C for 20 minutes, and the wet pellets were resuspended with 120 mL of PBS, pH
7.4 + 1 mM dithiothreitol (DTT), 1 mM PMSF. After sonication at 500 W for 3 seconds, on ice
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6 seconds for a total of 30 min, cell pellets were spun down at 13,000 rpm, 4°C for 30 min. After
centrifugation, the pellet was resuspended with 30 mL PBS, pH 7.4 + 8 M urea. After sonication
at 500W for 3 seconds, on ice 6 seconds for a total of 10 minutes, cell pellets were spun down at
13,000 rpm, 4°C for 30 min. After centrifugation, the solubilized pellet was loaded onto 3 mL
pre-equilibrated nickel affinity column. The protein was washed with 30 mL PBS, pH 7.4 +
20 mM imidazole + 8 M urea. The protein was eluted with 30 mL PBS, pH 8.0 + 50 mM imidaz-
ole + 8 M urea and then with 30 mL PBS, pH 8.0 + 500 mM imidazole, 8 M urea. The eluted
proteins were then loaded onto 3 mL pre-equilibrated Q Sepharose Fast Flow column (GE Life
Sciences, Catalog No. 17-0510-10). The flow through was pooled and refolded against PBS, pH
7.4 + 4 mMDTT at 4°C. After dialysis, the sample was centrifuged at 13,000 rpm for 30 min and
filtered through 0.22 μmmembrane. The GST and HIS tags were left intact from the fusion pro-
tein. The protein concentration was determined using the Bradford Protein Assay.
Luminex assay development
Protein coupling to MagPlex magnetic beads. All coupling procedures were carried out
at room temperature (22°C). Recombinant proteins were coupled to MagPlex Magnetic Micro-
spheres (Luminex, Austin; product # MC10026-01 and #MC10066-1) using 1-ethyl-3-
[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC)- N-hydroxysulfosuccinimide
(Sulfo NHS) reactions [25, 26]. Briefly, beads were washed and activated by using 50mM 2-
(N-morpholino)-ethanesulfonic acid (MES), pH 5, buffered saline (+ 0.85% NaCl and 0.05%
Tween-20). After 40 minutes of incubation using end-over-end mixing at dark with Sulfo-NHS
and EDC, beads were washed 2 times with MES buffered saline. The activated beads were then
transferred to a new tube and washed once more. Beads were resuspended in the MES buffer
without Tween-20 and 1.25 μg of each protein/1.25 x 106beads were added. The total volume
of reaction was brought to 500 μL with MES buffer without Tween-20. The coupling was per-
formed for 3 hours in the dark at room temperature by end-over-end mixing. Beads were
blocked with blocking buffer (PBS + 1% BSA + 0.05% sodium azide (NaN3), pH 7.4) for
30 minutes. The coupled beads were stored at 4°C in PBS + 1% BSA + 0.05% NaN3 + 0.05%
Tween-20 + phenylmethylsulfonyl fluoride (PMSF) (1:500), pepstatin (1:1,000), leupeptin
(1:1,000). The concentration of the beads was determined by using hemacytometer.
MagPlex immunoassay. All assays were carried out at room temperature (22°C). Fifty μL
of the working microsphere mixture (50 beads/μL in PBS + 0.3% Tween-20 + 5% non-fat dry
skim milk) and 50 μL of diluted sera (1:100 dilution in PBS + 0.3% Tween-20 + 5% non-fat dry
skim milk) were added to 96-well black, round-bottom plates (Costar, Catalog No. 3792, Fisher
Scientific). After 30 minutes incubation at room temperature with shaking (~800 rpm), the
beads were washed using Biotek Magnetic Washer ELx50 (2 minutes magnetic separation, and
then 2 cycles of dispensing 100 μL of PBS + Tween-20 0.3%, soaks for 40 seconds before aspira-
tion). Bound antibodies were detected using 50 μL of biotinylated mouse anti-human IgG
(clone H2, affinity purified, Southern Biotech, Birmingham, AL, Catalog No. 9042–08) diluted
1:200 in PBS + 1% BSA +0.05% NaN3. After 30 minutes incubation, the beads were washed as
before. As a detector, 50 μL/well of diluted R-phycoerythrin-labeled Streptavidin conjugate
(Invitrogen, Catalog No. S866) (1:250 dilution in PBS + 1% BSA+ 0.05% NaN3) was added and
incubated for another 30 minutes. After washing, the beads were resuspended in 100 μL/well of
PBS + 1% BSA + 0.05% NaN3 and analyzed using a Luminex 100 analyzer. The mean fluores-
cence intensity (MFI) from each well was determined by using Bio-Plex Manager Software, ver-
sion 6.02 (Bio-Rad). The mean fluorescence intensity minus the signal intensity of the blank
well was used in further analysis. Receiver operating characteristic (ROC) curves were used to
illustrate assay performance[27].
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Repeatability of the Luminex system. Intra- and inter-assay variability were determined
for low- and medium-reactive control samples by testing 6 samples per run for 12 different
times to produce 72 data points following the EP5-A2 (NCCLS) [28]. Low and medium reac-
tive samples are constructed by dilution strong pooled positive sera using pooled negative
human sera.
TES-Ag western blot
TES-Ag proteins were electrophoretically separated using Criterion TGX (Bio-Rad, Cat. # 567–
1092) at 10 ng/mm and then transferred to nitrocellulose membrane (Whatman Protran
BA83, Cat. # 10 541 103, 0.2m pore size).The blots were cut into 2.5 mm strips and stored in
PBS + 0.1% NaN3 at 4°C prior to use. Sera were tested and specific antibodies were detected as
described previously [29, 30]. A serum was considered positive if reactivity occurred with any
bands at 24, 28, 30, or 35 kDa [31, 32].
Data analysis
Data were tabulated and analyzed using Microsoft Excel. Determination of the cut-off value
and assay performance was obtained by using R statistical software version 3.0.1 (R Foundation
for Statistical Computing, Vienna, Austria) and pROC package [33]. To combine the results of
diagnostic tests, we used a method which finds optimal linear combination of multiple anti-
gens[27]. In short, this procedure searches for the coefficients a and b in the equation below:
¼ a  MFITcCTL1 þ b  MFITcTES26
(MFI minus background is shortened to MFI in the equation for simplicity). In this formula, a
and b are chosen to maximize the area under the ROC curve (AUC) and y is the combined
value of the two MFI values. In order to avoid bias in the computation of the AUC, the AUC is
estimated via cross-validation. Further details on the calculations can be found elsewhere [27].
Results
2D gel mass spectrometry
From the 2D gel electrophoresis and mass spectrometry analysis, we identified 24 hits/spots
that were reactive to T. canis positive serum, and lacked reactivity with both a B. procyonis posi-
tive baboon serum and a normal human serum (Fig 1A–1C). The corresponding protein spots
were excised from the silver-stained gel and prepared for MS analysis (Fig 1D). An initial MAS-
COT search revealed 3 hits from spots 17, 22, and 23.The excretory/secretory mucin, MUC-3,
from T. canis, was identified in spot 17, and excretory/secretory C-type lectin,Tc-CTL-1, from
T. canis, at spots 22 and 23 (Table 1).When the MS data were used to search a T. canis
Expressed Sequence Tag (EST) database, from 7 spots (2, 15, 17, 20, 22, 23, 24) we found nine
mRNAs (Histone H4, Actin containing A3R Repeat, Actin, Tc-MUC-3, Fibrinogen beta and
gamma chains, Glyceraldehyde 3-Phosphate Dehydrogenase, Elongation Factor, Tc-TES-26,
Tc-CTL-1) with acceptable scores and percent sequence coverage. However, we identified only
3 proteins of interest (Tc-MUC-3, Tc-TES-26, and Tc-CTL-1) (Table 2). Tc-TES-26 from T.
canis was identified as the protein in spot 20. The remaining 17 spots were determined to be
human protein contaminants.
Recombinant protein expression
We expressed Tc-CTL-1, Tc-TES-26, and Tc-MUC-3 in bacterial expression system. These
three antigens were expressed as fusion proteins with GST tags to allow easy recombinant
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protein purification and also for improving the coupling possibility of the proteins to the mag-
netic beads. The purity and antigenic potential of the proteins could be seen in Fig 2. Among
the three proteins, Tc-MUC-3 showed weaker reactivity when tested against the T. canis posi-
tive serum (Fig 2C).
Luminex assay development
The three antigens, Tc-CTL-1, Tc-TES-26 and Tc-MUC-3, were selected for further evaluation
in the Luminex assay based on the MS data. The Tc-MUC-3 antigen, after coupled to the
magnetic beads, did not show differentiation between positive and negative sera although the
protein performed well in the immunoblot format. No further analysis of Tc-MUC-3 was per-
formed. Tc-CTL-1 and Tc-TES-26 were coupled to the MagPlex Magnetic Beads and Luminex
based assays were developed. Each set of beads was tested using the defined serum batteries.
Luminex assay performance
The Tc-CTL-1 Luminex assay performed significantly better than the Tc-TES-26 (p< 0.001)
for diagnosis of visceral toxocariasis (Fig 3, Table 3). In comparison to the TES-Ag EIA, the
Tc-CTL-1 Luminex assay also performed well for detecting visceral toxocariasis, however, only
54% of OLM cases were detected using the Tc-CTL-1 Luminex compared to 100% using the
TES-Ag EIA (Table 3). We used the TES-Ag Western blot to better define the sera used from
the OLM cases; only 70% of the OLM sera were reactive in the TES-Ag Western blot. When we
restricted the OLM case definition to include only TES-Ag Western blot positive sera, the
Fig 1. 2-D gel electrophoresis, silver staining and western blotting of Toxocara canis Excretory
Secretory Antigens (TES-Ag). The TES-Ag sample was separated and analyzed using 2D gel
electrophoresis and western blotting. Three of the 2DE gels were transferred to nitrocellulose membranes
and probed with a strong EIA positive Toxocara human sera pool (A), a negative human serum sample (B),
and Baylisascaris procyonis positive serum (C).A reference gel was stained using silver stain (D). The circled
spots in D represent proteins that were excised and subjected to mass spectrometry analysis.
doi:10.1371/journal.pntd.0004168.g001
Table 1. Identified proteins frommass spectrometry analysis.
Spot Accession MW + (kDa) Score SC * (%) Toxocara canis-related Protein
17 gi|5732922 27.9 84.6 8.9 Excretory/Secretory mucin MUC-3
22 gi|2773355 23.6 164.6 5.4 Excretory/Secretory C-type lectin CTL-1
23 gi|2773355 23.6 221.2 20.1 Excretory/Secretory C-type lectin CTL-1
Note
+ = Molecular Weight
* = Sequence Coverage
doi:10.1371/journal.pntd.0004168.t001
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sensitivity and specificity increased 1% and 2% for Tc-CTL-1 and 3% and 3% for Tc-TES-26.
To establish the specificity of the Luminex based assays, we used the sera from infections other
than Toxocara spp. The Tc-TES-26 Luminex assay showed more cross-reactivity than the Tc-
CTL-1 Luminex; only amebiasis and E. nana infections cross-react with Tc-CTL-1 (Table 4).
Assay performance was improved when a combination of Tc-CTL-1 and Tc-TES-26 was
used (Fig 3 and Table 3). The combination of the two antigens increased the sensitivity to 99%
but lowered the specificity to 94% although this improvement was not statistically significant
compared to Tc-CTL-1 (p = 0.10).
The coefficients of variation (CV) for intra-plate assays were 5% for Tc-CTL-1 and 4% for
Tc-TES-26. For inter-plate variation, the CV for the low positive control was quite large at 23%
for Tc-CTL-1 and 31% for Tc-TES-26, probably because of the low value of the observations;
but for medium calibrator, the CV was 7% for Tc-CTL-1 and 12% for Tc-TES-26.
Discussion
The study confirmed previous studies on immunodominant TES antigens [1, 13, 16, 19, 20, 23,
24]. Briefly, we identified three major antigenic proteins from the TES-Ag, and based on these
findings, expressed those antigens for further analysis as diagnostic reagents. One antigen, Tc-
MUC-3, after coupled to Luminex beads, did not produce a functional assay. We have no
explanation for this, as we tried several methods of coupling including titration of antigens, dif-
ferent buffers, and pH conditions. It is possible that the low reactivity of this protein to positive
sample causes the failure for coupling the protein to the beads.
The performances of Tc-CTL-1 and Tc-TES-26 based on total IgG responses are compara-
ble to the reported performances of the same antigens. Yamasaki et al. (2000) [16], based on 11
subjects with toxocariasis, reported a sensitivity of 100% for Tc-CTL-1 and a specificity of 98%
(3 out of 142 cross-reactors sera). From the study of Mohamad et al. (2009) [15], and Norhaida
Table 2. Identified mRNA sequences from a T. canis expressed sequenced tag database.
Spot Accession MW + (kDa) Score SC * (%) Toxocara canis-related Protein
2 AA873915.1 17.1 220.0 19.6 Histone H4
2 BQ274136.1 20.3 217.8 20.1 Actin containing A3R Repeat
2 HO243979.1 31.4 189.1 9.3 Actin
2 BQ458030.1 19.1 156.3 16 Actin
15 AA873915.1 17.1 220.2 19.6 Histon H4
15 BQ274136.1 20.1 155.9 16.2 Actin containing A3R Repeat
17 AA873915.1 17.1 220.2 19.6 Histon H4
17 AA728645.1 12.7 84.6 11.6 Tc-MUC-3 (mucin-3)
17 BQ274202.1 17.7 75.1 5.5 Fibrinogen beta and gamma chains
17 BM965454.1 19.0 741 8.2 Glyceraldehyde 3- Phosphate Dehydrogenase
17 BM088866.1 16.6 62.1 10.5 Elongation Factor
20 AA836708.3 19.2 52.6 4.0 Tc-TES-26
22 AI080928.1 12.7 164.6 20.2 Tc-CTL-1, c-type lectin
23 AI080928.1 12.7 221.2 38.6 Tc-CTL-1, c-type lectin
24 HO243979.1 31.4 386.1 22.1 Actin
24 BQ275419.1 22.3 372.2 31.7 Actin
Note
+ = Molecular Weight
* = Sequence Coverage
doi:10.1371/journal.pntd.0004168.t002
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Fig 2. Purity and antigenicity of purified recombinant proteins. SDS-PAGE of the three recombinant
proteins. A. Tc-CTL-1; B. Tc-TES-26; C. Tc-MUC-3. The recombinant protein samples at a concentration of:
1–6.25 ng/mm; 2–3.125 ng/mm; 3–1.6 ng/mm, and 4–0.8 ng/mmwas treated with SDS and heated at 65°C
for 15 minutes, separated and analyzed using SDS gel electrophoresis and western blotting. Two gels were
transferred to nitrocellulose membranes and probed with a strong EIA positive Toxocara human sera pool, a
negative human serum sample diluted 1:100 in PBS/Tween 0.3%/5%milk, and one gel was incubated with
protein staining, Colloidal Gold Total Protein Stain (Bio-Rad, Cat. # 170–6527). M = Precision Plus Protein
Dual Xtra Standards (Biorad, Cat. #161–0377)
doi:10.1371/journal.pntd.0004168.g002
Fig 3. ROCCurves of Tc-CTL-1 and Tc-TES-26, and optimal linear combination for visceral larval migrans.ROC Curves of Tc-CTL-1, Tc-TES-26, and
the optimal linear combination were constructed based on Luminex-derived mean fluorescence intensity antigen for visceral larval migrans from 288 negative
U.S. serum samples + 134 heterologous parasitic infected serum samples and 204 visceral larval migrans positive serum samples; thresholds are calculated
with the highest sum of sensitivity and specificity and are represented on the plot with black dots and corresponding 95% confidence intervals.
doi:10.1371/journal.pntd.0004168.g003
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et al. (2008) [34], the sensitivity and the specificity of Tc-CTL-1 is 92–93% and 94–90%, respec-
tively. The Tc-CTL-1 in our study has a sensitivity of 90% and a specificity of 99%. The differ-
ences of the performances of the assays due to a possibility that Yamasaki study used small
number of positive sera and also soil-transmitted helminths were not prevalent in Japan. A
Low prevalence of soil-transmitted helminths might contribute to less background or reactivity
to the assay and will lower the cut-off points, thereby improving the sensitivity. In Norhaida
study, the group used IgG4, instead of total IgG [34]. For Tc-TES-26, Mohamad et al. (2009)
Table 3. Performance of Tc-CTL-1 and Tc-TES-26 Luminex based assays.
Tc-CTL-1 (%) (95% CI)* (N) Tc-TES-26 (%) (95% CI) (N) Tc-CTL-1 plus Tc-TES-26 TES Ag-Western Blot (%)
Sensitivity
- visceral larval migrans 90 (85–94) (204) 85 (79–89) (204) 99 100
- ocular larval migrans 54 (39–68) (50) 44 (30–59) (50) 64 70
Speciﬁcity 99 (97–100) (422) 91 (87–93) (422) 94 Not tested
Note
* = 95% Conﬁdence Interval
doi:10.1371/journal.pntd.0004168.t003
Table 4. Specificity of the Toxocariasis Luminex assay.
Conditions No. of Sera Tested Tc-TES-26 Tc-CTL-1
No. of Positives % Cross-reactivity No. of Positives % Cross-reactivity
US Negatives 288 20 7 2 0.7
Egyptian Negatives 14 2 14 0 0
Amebiasis 2 1 50 1 50
Ascariasis 6 2 33 0 0
Baylisascariasis 5 1 20 0 0
Clonorchiasis 3 0 0 0 0
Cryptosporidiasis 2 0 0 0 0
Cysticercosis 7 1 14 0 0
Dengue Fever 1 0 0 0 0
Echinococcosis 5 1 20 0 0
E. nana 2 2 100 1 50
Fasciolosis 2 0 0 0 0
Filariasis 3 0 0 0 0
Gnathostomiasis 2 0 0 0 0
Hepatitis 2 0 0 0 0
Hookworm 15 4 27 0 0
Hymenolopsis 8 0 0 0 0
Malaria 3 1 33 0 0
Paragonimiasis 4 1 25 0 0
Schistosomiasis 16 1 6 0 0
Strongyloidiasis 3 0 0 0 0
Taeniosis 5 0 0 0 0
Toxoplasmosis 5 0 0 0 0
Trichinellosis 12 2 17 0 0
Trichuriasis 6 2 33 0 0
Tuberculosis 1 0 0 0 0
doi:10.1371/journal.pntd.0004168.t004
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[15] reported the assay has a sensitivity of 80% and specificity of 96% (similar to Tc-TES-26
Luminex performance), but this performance was based on IgG4 responses. Our assay was not
based on specific IgG4 detection and it is possible that we could improve the sensitivity and
specificity of the assay if we were to use the IgG4 specific responses [15, 34].
Recombinant-based assays to determine antibody responses usually have lower sensitivity
than those based on native/crude antigens because reactivity with multiple antigens can occur
when crude mixtures are used. As expected, the assays developed here using Tc-CTL-1 and Tc-
TES-26, are less sensitive than the TES-Ag EIA or TES-Ag Western Blot, which utilize a crude
parasite antigen. However, the combination of the two antigens resulted in an improved sensi-
tivity of 99% for VLM detection that equaled the sensitivity of the TES-Ag Western Blot. Not
unexpectedly, when sensitivity was maximized, the assay specificity decreased to 94% when the
combination of two antigens was used. This specificity is not optimum, but it is still much bet-
ter than the reported specificities of TES-Ag EIAs which are approximately 85% [4]. Although
the Luminex based assays all represented improvements in detecting VLM, all were less sensi-
tive than the TES-Ag EIA or even the TES-Ag Western blot method for detecting OLM cases.
While additional antigens might improve the sensitivity for detection of OLM, we wonder how
many individual antigens might be needed since the TES-Ag western blot, which is a complex
mixture of multiple antigens failed to detect 30% of OLM subjects. Compared to the reference
TES-Ag EIA, the use of the Luminex platform has advantages: more samples could be tested
concurrently and downstream, a multiplex assay could be developed to distinguish human lar-
val migrans syndromes caused by other helminths such as B. procyonis, another important
cause of larval migrans in the U.S., as well as other larval helminths species [2, 35].
Although the Luminex-based assay offers advantages against the EIA (in term of perfor-
mance and multiplexing capability), the capital cost is much higher than for an EIA [36]. If the
system is only used for detecting responses against single antigen, the Luminex-based assay is
not cost effective and does not offer advantage on time-saving. For each additional antigen, the
time and cost savings for running the Luminex-based assay are much better than running sev-
eral EIA. The capital cost for running Luminex-based assay even could be reduced further by
using a more robust, field-friendly system of MagPix that has similar performance to the Lumi-
nex platform. The only disadvantage of MagPix is that the capability for multiplexing is only
up to 50 antigens (not 100 antigens as for the Luminex system). In the term of skill needed,
Luminex-based assay is similar to the requirement of the skill for running an EIA.
Conclusions
Recombinant antigen based assays in the Luminex platform for visceral toxocariasis perform
similarly to the existing TES-AgWestern Blot and better than the TES-Ag EIA method. The
utilization of the Luminex assay significantly diminishes the need for native parasite materials
which can be expensive and cause data variability.
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